203 related articles for article (PubMed ID: 35835117)
21. Integrated cistromic and expression analysis of amplified NKX2-1 in lung adenocarcinoma identifies LMO3 as a functional transcriptional target.
Watanabe H; Francis JM; Woo MS; Etemad B; Lin W; Fries DF; Peng S; Snyder EL; Tata PR; Izzo F; Schinzel AC; Cho J; Hammerman PS; Verhaak RG; Hahn WC; Rajagopal J; Jacks T; Meyerson M
Genes Dev; 2013 Jan; 27(2):197-210. PubMed ID: 23322301
[TBL] [Abstract][Full Text] [Related]
22. Loss of FOXA1/2 is essential for the epithelial-to-mesenchymal transition in pancreatic cancer.
Song Y; Washington MK; Crawford HC
Cancer Res; 2010 Mar; 70(5):2115-25. PubMed ID: 20160041
[TBL] [Abstract][Full Text] [Related]
23. Foxa1 and Foxa2 positively and negatively regulate Shh signalling to specify ventral midbrain progenitor identity.
Mavromatakis YE; Lin W; Metzakopian E; Ferri AL; Yan CH; Sasaki H; Whisett J; Ang SL
Mech Dev; 2011; 128(1-2):90-103. PubMed ID: 21093585
[TBL] [Abstract][Full Text] [Related]
24. The FOXA1 transcriptional network coordinates key functions of primary human airway epithelial cells.
Paranjapye A; Mutolo MJ; Ebron JS; Leir SH; Harris A
Am J Physiol Lung Cell Mol Physiol; 2020 Jul; 319(1):L126-L136. PubMed ID: 32432922
[TBL] [Abstract][Full Text] [Related]
25. KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung.
Hwang DH; Sholl LM; Rojas-Rudilla V; Hall DL; Shivdasani P; Garcia EP; MacConaill LE; Vivero M; Hornick JL; Kuo FC; Lindeman NI; Dong F
J Thorac Oncol; 2016 Apr; 11(4):496-503. PubMed ID: 26829311
[TBL] [Abstract][Full Text] [Related]
26. Tumor Suppressor Activity of Selenbp1, a Direct Nkx2-1 Target, in Lung Adenocarcinoma.
Caswell DR; Chuang CH; Ma RK; Winters IP; Snyder EL; Winslow MM
Mol Cancer Res; 2018 Nov; 16(11):1737-1749. PubMed ID: 30002193
[TBL] [Abstract][Full Text] [Related]
27. SMAD3 prevents binding of NKX2.1 and FOXA1 to the SpB promoter through its MH1 and MH2 domains.
Minoo P; Hu L; Zhu N; Borok Z; Bellusci S; Groffen J; Kardassis D; Li C
Nucleic Acids Res; 2008 Jan; 36(1):179-88. PubMed ID: 18003659
[TBL] [Abstract][Full Text] [Related]
28. SOX9 dependent FOXA1 expression promotes tumorigenesis in lung carcinoma.
Wang X; Yin Y; Du R
Biochem Biophys Res Commun; 2019 Aug; 516(1):236-244. PubMed ID: 31221478
[TBL] [Abstract][Full Text] [Related]
29. Kras(G12D) and Nkx2-1 haploinsufficiency induce mucinous adenocarcinoma of the lung.
Maeda Y; Tsuchiya T; Hao H; Tompkins DH; Xu Y; Mucenski ML; Du L; Keiser AR; Fukazawa T; Naomoto Y; Nagayasu T; Whitsett JA
J Clin Invest; 2012 Dec; 122(12):4388-400. PubMed ID: 23143308
[TBL] [Abstract][Full Text] [Related]
30. Foxa1 and Foxa2 are required for formation of the intervertebral discs.
Maier JA; Lo Y; Harfe BD
PLoS One; 2013; 8(1):e55528. PubMed ID: 23383217
[TBL] [Abstract][Full Text] [Related]
31. Expression and role of Foxa proteins in prostate cancer.
Mirosevich J; Gao N; Gupta A; Shappell SB; Jove R; Matusik RJ
Prostate; 2006 Jul; 66(10):1013-28. PubMed ID: 16001449
[TBL] [Abstract][Full Text] [Related]
32. Transcription factors FOXA1 and FOXA2 maintain dopaminergic neuronal properties and control feeding behavior in adult mice.
Pristerà A; Lin W; Kaufmann AK; Brimblecombe KR; Threlfell S; Dodson PD; Magill PJ; Fernandes C; Cragg SJ; Ang SL
Proc Natl Acad Sci U S A; 2015 Sep; 112(35):E4929-38. PubMed ID: 26283356
[TBL] [Abstract][Full Text] [Related]
33. NKX2-1 controls lung cancer progression by inducing DUSP6 to dampen ERK activity.
Ingram K; Samson SC; Zewdu R; Zitnay RG; Snyder EL; Mendoza MC
Oncogene; 2022 Jan; 41(2):293-300. PubMed ID: 34689179
[TBL] [Abstract][Full Text] [Related]
34. Suppression of lung adenocarcinoma progression by Nkx2-1.
Winslow MM; Dayton TL; Verhaak RG; Kim-Kiselak C; Snyder EL; Feldser DM; Hubbard DD; DuPage MJ; Whittaker CA; Hoersch S; Yoon S; Crowley D; Bronson RT; Chiang DY; Meyerson M; Jacks T
Nature; 2011 May; 473(7345):101-4. PubMed ID: 21471965
[TBL] [Abstract][Full Text] [Related]
35. NKX2-1-mediated p53 expression modulates lung adenocarcinoma progression via modulating IKKβ/NF-κB activation.
Chen PM; Wu TC; Cheng YW; Chen CY; Lee H
Oncotarget; 2015 Jun; 6(16):14274-89. PubMed ID: 25881545
[TBL] [Abstract][Full Text] [Related]
36. Foxa1 and Foxa2 regulate multiple phases of midbrain dopaminergic neuron development in a dosage-dependent manner.
Ferri AL; Lin W; Mavromatakis YE; Wang JC; Sasaki H; Whitsett JA; Ang SL
Development; 2007 Aug; 134(15):2761-9. PubMed ID: 17596284
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical localization of Foxa1 and Foxa2 in mouse embryos and adult tissues.
Besnard V; Wert SE; Hull WM; Whitsett JA
Gene Expr Patterns; 2004 Dec; 5(2):193-208. PubMed ID: 15567715
[TBL] [Abstract][Full Text] [Related]
38. Epithelial-mesenchymal transition and FOXA genes during tobacco smoke carcinogen induced transformation of human bronchial epithelial cells.
Bersaas A; Arnoldussen YJ; Sjøberg M; Haugen A; Mollerup S
Toxicol In Vitro; 2016 Sep; 35():55-65. PubMed ID: 27221058
[TBL] [Abstract][Full Text] [Related]
39. FOXA2 Cooperates with Mutant KRAS to Drive Invasive Mucinous Adenocarcinoma of the Lung.
Tomoshige K; Stuart WD; Fink-Baldauf IM; Ito M; Tsuchiya T; Nagayasu T; Yamatsuji T; Okada M; Fukazawa T; Guo M; Maeda Y
Cancer Res; 2023 May; 83(9):1443-1458. PubMed ID: 37067057
[TBL] [Abstract][Full Text] [Related]
40. Foxa1 and Foxa2 regulate bile duct development in mice.
Li Z; White P; Tuteja G; Rubins N; Sackett S; Kaestner KH
J Clin Invest; 2009 Jun; 119(6):1537-45. PubMed ID: 19436110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
